Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 23, 2023, Tram Tran, M.D. notified Arbutus Biopharma Corporation (the "Company") of her decision to resign from the Board of Directors of the Company and all committees thereof, effective as of February 26, 2023. The resignation of Dr. Tran is not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

A copy of the Company's press release announcing Dr. Tran's resignation effective as of February 26, 2023, is filed herewith as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits.

Exhibit Number    Description

  99.1              Press Release dated January 27, 2023
104               Cover Page Interactive Data File (embedded within the Inline
                  XBRL document)

© Edgar Online, source Glimpses